India to South Africa: Glibenclamide Export Trade Route

The India to South Africa Glibenclamide corridor is one of India's established pharmaceutical export routes, with 39 shipments documented worth a combined $469.0K USD. The route is dominated by RUSAN PHARMA LIMITED, which alone accounts for roughly 23% of all export value, reflecting the consolidated nature of India's glibenclamide manufacturing sector.

Across 13 active suppliers, the average shipment value stands at $12.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 16.6%, placing it at rank #11 among India's top glibenclamide export destinations globally.

On the import side, key buyers of Indian glibenclamide in South Africa include OETHMAAN BIOSIMS PTY LIMITED, BIOTECH LABORATORIES (PTY) LTD , OETHMAAN BIOSIMS PTY LTD and 10 others. OETHMAAN BIOSIMS PTY LIMITED is the single largest importer with 7 shipments valued at $114.5K USD.

India's glibenclamide exports to South Africa are driven primarily by a handful of large-scale manufacturers. RUSAN PHARMA LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 13 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — RUSAN PHARMA LIMITED, J B CHEMICALS AND PHARMACEUTICALS LIMITED , MILAN LABORATORIES I PRIVATE LIMITED — together account for 55% of total trade value on this route. The average shipment value of $12.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical goods/ harmless medicinesglibenclamide tablets 5mg each uncoated tablet contains glibenclamide 5mg and glibenclamide 5 oethmaantablets prp56, suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, OETHMAAN BIOSIMS PTY LIMITED is the largest importer with 7 shipments worth $114.5K USD — representing 24% of all glibenclamide imports from India on this route. A total of 13 buyers are active on this corridor.